Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

被引：0
|
作者：
Mikio Sugimoto
Takuma Kato
Yoichiro Tohi
Yosuke Shimizu
Ryuji Matsumoto
Takahiro Inoue
Yutaka Takezawa
Kimihiko Masui
Hiroshi Sasaki
Hiromi Hirama
Shiro Saito
Shin Egawa
Toshiyuki Kamoto
Satoshi Teramukai
Shinsuke Kojima
Takashi Kikuchi
Yoshiyuki Kakehi
机构：
[1] Kagawa University,Department of Urology, Faculty of Medicine
[2] Kobe City Nishi-Kobe Medical Center,Department of Urology
[3] Hokkaido University Graduate School of Medicine,Department of Urology
[4] Kyoto University,Department of Urology, Graduate School of Medicine
[5] Isesaki Municipal Hospital,Department of Urology
[6] Otsu City Hospital,Department of Urology
[7] Jikei University School of Medicine,Department of Urology
[8] National Hospital Organization Tokyo Medical Center,Department of Urology
[9] University of Miyazaki,Department of Urology, Faculty of Medicine
[10] Kyoto Prefectural University of Medicine,Department of Biostatistics
[11] Foundation for Biomedical Research and Innovation at Kobe Translational Research Center for Medical Innovation,undefined
来源：
BMC Urology | / 22卷
关键词：
Combined androgen blockade; Enzalutamide; Non-metastatic castration-resistant prostate cancer; Progression-free survival; Radical treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study
    Sugimoto, Mikio
    Kato, Takuma
    Tohi, Yoichiro
    Shimizu, Yosuke
    Matsumoto, Ryuji
    Inoue, Takahiro
    Takezawa, Yutaka
    Masui, Kimihiko
    Sasaki, Hiroshi
    Hirama, Hiromi
    Saito, Shiro
    Egawa, Shin
    Kamoto, Toshiyuki
    Teramukai, Satoshi
    Kojima, Shinsuke
    Kikuchi, Takashi
    Kakehi, Yoshiyuki
    BMC UROLOGY, 2022, 22 (01)
  • [2] Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer
    Bagguley, Dominic
    Ong, Sean
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 320 - 321
  • [3] Sequential therapy with darolutamide in patients with non-metastatic castration-resistant prostate cancer resistant to enzalutamide or apalutamide
    Fujmoto, Saizo
    Fujita, Kazutoshi
    Nishimoto, Mitsuhisa
    Hamaguchi, Mamoru
    Kuwahara, Ken
    Hashimoto, Mamoru
    Adomi, Shogo
    Minami, Takafumi
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    CANCER MEDICINE, 2023, 12 (03): : 3176 - 3179
  • [4] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [5] Apalutamide for the Treatment of non-metastatic castration-resistant Prostate Cancer
    Miller, Kurt
    ONKOLOGE, 2019, 25 (03): : 275 - 276
  • [6] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
  • [7] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Soum D. Lokeshwar
    Zachary Klaassen
    Fred Saad
    Nature Reviews Urology, 2021, 18 : 433 - 442
  • [8] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Lokeshwar, Soum D.
    Klaassen, Zachary
    Saad, Fred
    NATURE REVIEWS UROLOGY, 2021, 18 (07) : 433 - 442
  • [9] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [10] New treatment standard for patients with non-metastatic castration-resistant prostate cancer
    Alekseev, B. Ya
    ONKOUROLOGIYA, 2018, 14 (03): : 68 - 77
12345